Cidara doses first group in phase 1 trial of CD388 for treating/preventing influenza
March 31 2022 - 9:53AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Apr 2023 to Apr 2024